Ann: Supply of Membranes to Prime Biologics Pte Ltd, page-4

BT,
IMO there needs to be further explanation now!  In the November 2013 presentation we were told:

"NuSep Membrane is the heart of the PrIME Technology
Every new application of PrIME will require a perpetual ongoing supply of
the consumable membranes. Thus each new application becomes a new
annuity income stream for NuSep.
NuSep has intellectual property covering the membrane manufacturing
process and the disposable cartridge concept. Additional intellectual
property will be created to protect each application.
Ultimately, it will be the consumable membrane income stream that will
create the most value for NuSep. In time NuSep will become a consumable
membranes company."

So how can Alison Coutts now 12 months later simply say:

"Ceasing supply of membranes to PrIME will not have any adverse financial effect on NuSep."

.....without elaborating?  Unfortunately I can hear FX and Kosenar saying 'told you so'!  

However there may be a logical explanation, if for example, NuSep couldn't produce the requisite product profitably?  The market needs more information IMHO.
DYOR
Kind regards,